文献
J-GLOBAL ID:202202263839233361
整理番号:22A0328859
日本におけるSARS-CoV-2に対するAZD1222(ChAdOx1 nCoV-19)の免疫原性と安全性: 二重盲検無作為化対照第1/2相試験【JST・京大機械翻訳】
Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial
著者 (11件):
Asano Michiko
(Medical Science, BioPharmaceuticals, R&D, AstraZeneca, Tokyo, Japan)
,
Okada Hiroshi
(Medical Science, BioPharmaceuticals, R&D, AstraZeneca, Osaka, Japan)
,
Itoh Yohji
(Science and Data Analytics, Oncology R&D, AstraZeneca, Osaka, Japan)
,
Hirata Hajime
(Clinical Science, BioPharmaceuticals, R&D, AstraZeneca, Osaka, Japan)
,
Ishikawa Kensuke
(Science and Data Analytics, R&D, AstraZeneca, Osaka, Japan)
,
Yoshida Erika
(Biopharma Clinical Operations, Development Operations, BioPharmaceuticals R&D, AstraZeneca, Tokyo, Japan)
,
Matsui Akiko
(Science and Data Analytics, R&D, AstraZeneca, Osaka, Japan)
,
Kelly Elizabeth J.
(Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA)
,
Shoemaker Kathryn
(Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA)
,
Olsson Urban
(Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden)
,
Vekemans Johan
(Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden)
資料名:
International Journal of Infectious Diseases
(International Journal of Infectious Diseases)
巻:
114
ページ:
165-174
発行年:
2022年
JST資料番号:
W3271A
ISSN:
1201-9712
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)